Home > Healthcare > Medical Devices > Diagnostic Devices > Microbiology Testing Market

Microbiology Testing Market Size

Report ID: GMI5821
Published Date: May 2023
Report Format: PDF

Download Free Sample

Microbiology Testing Market Size

Microbiology Testing Market size was valued at around USD 4.9 billion in 2022 and is projected to reach over USD 11.9 billion by the end of 2032 owing to increasing prevalence of infectious diseases and outbreak of pandemics coupled with technological advancements in microbiology testing products.

To get key market trends

Download Free Sample

Additionally, supportive government initiatives and rising healthcare expenditure has fueled the demand for screening of several ailments including infectious, bacterial, and fungal diseases. Developing healthcare expenditure, rising private-public funding for research on infectious diseases, growing disposable income are some of the major factors responsible for increased adoption of microbiology testing across the world.

Microbiology testing are laboratory analysis of samples to identify and diagnose infectious diseases caused by microorganisms such as bacteria, viruses, fungi, and parasites. These testing are intended to manage chronic diseases, implementing appropriate infection control measures, and optimizing patient care.

Microbiology Testing Market Report Attributes
Report Attribute	Details
Base Year:	2022
Microbiology Testing Market Size in 2022:	USD 4.9 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	9.3%
2032 Value Projection:	USD 11.9 Billion
Historical Data for:	2018 to 2022
No. of Pages:	190
Tables, Charts & Figures:	451
Segments covered:	Product, Test Type, Application, End-use, and Region
Growth Drivers:	Technological Advancements in Microbiology Testing Rising incidence of infectious diseases and outbreak of epidemics Growing demand for point-of-care testing Increasing number of aerobic and anaerobic tests
Pitfalls & Challenges:	High cost of microbiology instruments Dearth of skilled professionals

Learn more about the key segments shaping this market

Download Free Sample

ede the market growth in the coming years. Limited availability of resources and lack of formal training programs focused on microbiology testing instruments to acquire the necessary skills is anticipated to impede the market progress. Additionally, evolving technological advancements by introducing new features and techniques in microbiology testing can pose a challenge among healthcare professionals in frequent adoption of these techniques and instruments.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

The global market for microbiology testing was worth around USD 4.9 billion in 2022 and is estimated to amass more than USD 11.9 billion by 2032 owing to the outbreak of pandemics, coupled with technological advancements in microbiology testing products.

Instruments accounted for more than 63% of the microbiology testing market revenue in 2022 and are set to record significant growth in adoption driven by several factors such as technological advancements, expanded testing volume, and rapid and accurate results, among others.

The U.S. market size is estimated to reach USD 4.4 billion by the end of 2032 owing to the presence of key market players and an increase in the occurrences of chronic diseases.

The microbiology testing industry consists of top companies such as Abbott Laboratories, Agilent Technologies Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation (Cepheid Inc.), F. Hoffmann-La Roche Ltd, Hologic Corporation, Merck KGaA, NEOGEN Corporation, QIAGEN, Shimadzu Corporation, and Thermo Fisher Scientific Inc., among others.